Literature DB >> 10805802

AIS is an oncogene amplified in squamous cell carcinoma.

K Hibi1, B Trink, M Patturajan, W H Westra, O L Caballero, D E Hill, E A Ratovitski, J Jen, D Sidransky.   

Abstract

We and others recently isolated a human p53 homologue (p40/p51/p63/p73L) and localized the gene to the distal long arm of chromosome 3. Here we sought to examine the role of p40/p73L, two variants lacking the N-terminal transactivation domain, in cancer. Fluorescent in situ hybridization (FISH) analysis revealed frequent amplification of this gene locus in primary squamous cell carcinoma of the lung and head and neck cancer cell lines. (We named this locus AIS for amplified in squamous cell carcinoma.) Furthermore, amplification of the AIS locus was accompanied by RNA and protein overexpression of a variant p68(AIS) lacking the terminal transactivation domain. Protein overexpression in primary lung tumors was limited to squamous cell carcinoma and tumors known to harbor a high frequency of p53 mutations. Overexpression of p40(AIS) in Rat 1a cells led to an increase in soft agar growth and tumor size in mice. Our results support the idea that AIS plays an oncogenic role in human cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805802      PMCID: PMC25851          DOI: 10.1073/pnas.97.10.5462

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes.

Authors:  R Parsa; A Yang; F McKeon; H Green
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.

Authors:  N Brass; A Rácz; D Heckel; K Remberger; G W Sybrecht; E U Meese
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

4.  Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  I Petersen; M Bujard; S Petersen; G Wolf; A Goeze; A Schwendel; H Langreck; K Gellert; M Reichel; K Just; S du Manoir; T Cremer; M Dietel; T Ried
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

5.  Tetranucleotide repeat polymorphism in RAF1.

Authors:  L Mao; D Sidransky
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

6.  Mutation and transcription analyses of the p63 gene in cervical carcinoma.

Authors:  H Nishi; K Isaka; Y Sagawa; S Usuda; A Fujito; H Ito; M Senoo; H Kato; M Takayama
Journal:  Int J Oncol       Date:  1999-12       Impact factor: 5.650

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  Participation of cyclin A in Myc-induced apoptosis.

Authors:  A T Hoang; K J Cohen; J F Barrett; D A Bergstrom; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  Loss of H19 imprinting in esophageal cancer.

Authors:  K Hibi; H Nakamura; A Hirai; Y Fujikake; Y Kasai; S Akiyama; K Ito; H Takagi
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

View more
  144 in total

1.  Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.

Authors:  Yiping Huang; Alice Y Chuang; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  p63 and p73, the ancestors of p53.

Authors:  V Dötsch; F Bernassola; D Coutandin; E Candi; G Melino
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-19       Impact factor: 10.005

3.  Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role.

Authors:  Elia Guadagno; Marialaura Del Basso De Caro; Sara Pignatiello; Concetta Sciammarella; Domenico Solari; Paolo Cappabianca; Francesco Maiuri; Flavia Dones
Journal:  J Neurooncol       Date:  2016-07-09       Impact factor: 4.130

4.  Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation.

Authors:  Yingchun Li; Melissa J Peart; Carol Prives
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

5.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

6.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  p63 deficiency activates a program of cellular senescence and leads to accelerated aging.

Authors:  William M Keyes; Ying Wu; Hannes Vogel; Xuecui Guo; Scott W Lowe; Alea A Mills
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

Review 8.  [Surgical treatment options for squamous cell carcinoma of the oral cavity].

Authors:  Michael Rasse
Journal:  Wien Med Wochenschr       Date:  2008

9.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

10.  Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells.

Authors:  Yun-Feng He; Dai-Yin Tian; Zheng-Jin Yi; Zhi-Kang Yin; Chun-Li Luo; Wei Tang; Xiao-Hou Wu
Journal:  Asian J Androl       Date:  2012-08-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.